Aspen Aerogels (NYSE:ASPN) Given New $20.00 Price Target at Canaccord Genuity Group

Aspen Aerogels (NYSE:ASPN) had its price objective dropped by Canaccord Genuity Group from $28.00 to $20.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the construction company’s stock. Canaccord Genuity Group’s target price points to a potential upside of 56.37% from the stock’s previous close.

A number of other research analysts have also issued reports on ASPN. Piper Sandler decreased their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Barclays cut their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. HC Wainwright reissued a “buy” rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. StockNews.com raised Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. Finally, Roth Mkm reduced their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research report on Friday, November 8th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $29.11.

Aspen Aerogels Trading Up 0.6 %

Aspen Aerogels stock opened at $12.79 on Thursday. Aspen Aerogels has a 52 week low of $10.75 and a 52 week high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $1.05 billion, a price-to-earnings ratio of 1,280.28 and a beta of 2.14. The stock has a 50-day moving average price of $13.63 and a 200 day moving average price of $20.37.

Institutional Trading of Aspen Aerogels

A number of hedge funds and other institutional investors have recently made changes to their positions in ASPN. Franklin Resources Inc. grew its position in shares of Aspen Aerogels by 5.3% during the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock worth $815,000 after acquiring an additional 1,483 shares during the last quarter. nVerses Capital LLC lifted its holdings in Aspen Aerogels by 45.0% in the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after acquiring an additional 1,800 shares during the period. Point72 Hong Kong Ltd acquired a new stake in shares of Aspen Aerogels in the second quarter valued at about $84,000. Quent Capital LLC purchased a new stake in shares of Aspen Aerogels during the 3rd quarter worth approximately $118,000. Finally, Point72 DIFC Ltd purchased a new stake in shares of Aspen Aerogels in the 2nd quarter worth about $121,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.